WELLS FARGO & COMPANY/MN - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 24 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2016$0171
+3320.0%
0.00%
Q4 2015$05
-99.5%
0.00%
Q3 2015$01,0050.0%0.00%
Q2 2015$01,005
+9950.0%
0.00%
Q1 2015$010
+100.0%
0.00%
Q4 2014$050.0%0.00%
Q3 2014$050.0%0.00%
Q2 2014$050.0%0.00%
Q1 2014$050.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q2 2014
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,252,964$6,804,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 175,815$531,0000.13%
THOMPSON DAVIS & CO., INC. 0$9,0000.01%
Spark Investment Management LLC 11,200$33,0000.01%
Virtu KCG Holdings LLC 55,599$167,0000.00%
Ground Swell Capital, LLC 302$1,0000.00%
JANE STREET GROUP, LLC 62,219$188,0000.00%
Tower Research Capital LLC (TRC) 1,668$5,0000.00%
DIMENSIONAL FUND ADVISORS LP 61$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 11$33,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders